After a melanoma diagnosis, mRNA cancer vaccine delivered a patient hope — and a path forward

When drugmakers Merck and Moderna announced promising results in August from a late-stage trial of adding an mRNA cancer vaccine to immunotherapy, it was heralded as potentially powerful new way of fighting tumors. But the data don’t show what such…

Read the full story at STAT ↗